These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 32052375)
1. Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates. Marcinkowska M; Śniecikowska J; Fajkis N; Paśko P; Franczyk W; Kołaczkowski M CNS Drugs; 2020 Mar; 34(3):243-268. PubMed ID: 32052375 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotic treatment of psychosis and agitation in the elderly. Daniel DG J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017 [TBL] [Abstract][Full Text] [Related]
3. Risperidone for the treatment of behavioral and psychological symptoms of dementia. Tune LE J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986 [TBL] [Abstract][Full Text] [Related]
4. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506 [TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics for the treatment of dementia-related behaviors: an update. Daiello LA Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience. Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study. Smeets CHW; Zuidema SU; Hulshof TA; Smalbrugge M; Gerritsen DL; Koopmans RTCM; Luijendijk HJ J Clin Epidemiol; 2018 Sep; 101():17-27. PubMed ID: 29782995 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes. Mueller C; John C; Perera G; Aarsland D; Ballard C; Stewart R Eur J Epidemiol; 2021 Jan; 36(1):89-101. PubMed ID: 32415541 [TBL] [Abstract][Full Text] [Related]
9. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. Salzman C; Jeste DV; Meyer RE; Cohen-Mansfield J; Cummings J; Grossberg GT; Jarvik L; Kraemer HC; Lebowitz BD; Maslow K; Pollock BG; Raskind M; Schultz SK; Wang P; Zito JM; Zubenko GS J Clin Psychiatry; 2008 Jun; 69(6):889-98. PubMed ID: 18494535 [TBL] [Abstract][Full Text] [Related]
10. The role of typical and atypical antipsychotic medications in the management of agitation and aggression. Buckley PF J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action. Raskind MA; Wang LY Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502 [No Abstract] [Full Text] [Related]
12. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease. Creese B; Da Silva MV; Johar I; Ballard C Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis. Gobbi G; Gaudreau PO; Leblanc N J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186 [TBL] [Abstract][Full Text] [Related]
14. Risperidone for Psychosis-Induced Aggression or Agitation. Scruth E Issues Ment Health Nurs; 2019 Nov; 40(11):988-989. PubMed ID: 31381459 [No Abstract] [Full Text] [Related]
15. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication. Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660 [TBL] [Abstract][Full Text] [Related]
16. Risks and benefits of antipsychotic drugs in elderly patients with dementia. Howland RH J Psychosoc Nurs Ment Health Serv; 2008 Nov; 46(11):19-23. PubMed ID: 19051574 [TBL] [Abstract][Full Text] [Related]
17. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555 [TBL] [Abstract][Full Text] [Related]
18. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients. Zaraa AS Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642 [No Abstract] [Full Text] [Related]
19. Agitation and psychosis in dementia. Ballard C Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863 [No Abstract] [Full Text] [Related]
20. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]